The Valley Desk

ArticleESMO openPublished

Neoadjuvant talazoparib, irinotecan, and standard chemotherapy for early breast cancer in the I-SPY2 trial

12 of 38 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
ESMO open
Published
Subject terms
Clinical Trials; Neoadjuvant Therapy; Early Breast Cancer; Parp Inhibitors
PubMed ID
43044269
Added to directory
Source checked

Report a correction or request removal